全文获取类型
收费全文 | 2809篇 |
免费 | 253篇 |
国内免费 | 413篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 24篇 |
妇产科学 | 19篇 |
基础医学 | 323篇 |
口腔科学 | 20篇 |
临床医学 | 428篇 |
内科学 | 432篇 |
皮肤病学 | 21篇 |
神经病学 | 132篇 |
特种医学 | 112篇 |
外国民族医学 | 1篇 |
外科学 | 319篇 |
综合类 | 593篇 |
一般理论 | 1篇 |
预防医学 | 179篇 |
眼科学 | 37篇 |
药学 | 396篇 |
1篇 | |
中国医学 | 144篇 |
肿瘤学 | 265篇 |
出版年
2024年 | 11篇 |
2023年 | 29篇 |
2022年 | 99篇 |
2021年 | 115篇 |
2020年 | 88篇 |
2019年 | 78篇 |
2018年 | 82篇 |
2017年 | 90篇 |
2016年 | 77篇 |
2015年 | 99篇 |
2014年 | 138篇 |
2013年 | 125篇 |
2012年 | 155篇 |
2011年 | 186篇 |
2010年 | 129篇 |
2009年 | 102篇 |
2008年 | 95篇 |
2007年 | 220篇 |
2006年 | 120篇 |
2005年 | 134篇 |
2004年 | 149篇 |
2003年 | 243篇 |
2002年 | 206篇 |
2001年 | 163篇 |
2000年 | 97篇 |
1999年 | 75篇 |
1998年 | 48篇 |
1997年 | 43篇 |
1996年 | 43篇 |
1995年 | 44篇 |
1994年 | 33篇 |
1993年 | 20篇 |
1992年 | 22篇 |
1991年 | 21篇 |
1990年 | 24篇 |
1989年 | 19篇 |
1988年 | 15篇 |
1987年 | 12篇 |
1986年 | 8篇 |
1985年 | 6篇 |
1984年 | 5篇 |
1983年 | 4篇 |
1982年 | 1篇 |
1979年 | 2篇 |
排序方式: 共有3475条查询结果,搜索用时 296 毫秒
101.
重型创伤性颅脑损伤(TBI)后患者颅内压(ICP)升高是导致死亡或致残的主要原因之一。ICP监测是持续监测患者颅内情况和指导处理异常ICP的重要手段。本文就近年来有关ICP监测在重型TBI患者中的临床应用进行综述。 相似文献
102.
Jiao Ma Pin Lu Ailin Guo Shuhua Cheng Hongliang Zong Peter Martin Morton Coleman Y. Lynn Wang 《British journal of haematology》2014,166(6):849-861
Ibrutinib inhibits Bruton tyrosine kinase (BTK), a key component of early B‐cell receptor (BCR) signalling pathways. A multicentre phase 2 trial of ibrutinib in patients with relapsed/refractory mantle cell lymphoma (MCL) demonstrated a remarkable response rate. However, approximately one‐third of patients have primary resistance to the drug while other patients appear to lose response and develop secondary resistance. Understanding the molecular mechanisms underlying ibrutinib sensitivity is of paramount importance. In this study, we investigated cell lines and primary MCL cells that display differential sensitivity to ibrutinib. We found that the primary cells display a higher BTK activity than normal B cells and MCL cells show differential sensitivity to BTK inhibition. Genetic knockdown of BTK inhibits the growth, survival and proliferation of ibrutinib‐sensitive but not resistant MCL cell lines, suggesting that ibrutinib acts through BTK to produce its anti‐tumour activities. Interestingly, inhibition of ERK1/2 and AKT, but not BTK phosphorylation per se, correlates well with cellular response to BTK inhibition in cell lines as well as in primary tumours. Our study suggests that, to prevent primary resistance or to overcome secondary resistance to BTK inhibition, a combinatory strategy that targets multiple components or multiple pathways may represent the most effective approach. 相似文献
103.
104.
105.
Zuo XR Zhang R Jiang X Li XL Zong F Xie WP Wang H Jing ZC 《The American journal of cardiology》2012,109(12):1801-1806
Although intravenous adenosine is recommended for acute vasodilator testing in patients with pulmonary hypertension, long-term outcomes in acute responders treated with calcium channel blockers (CCBs) who are identified by adenosine remain unknown. In this study, the value of adenosine for identifying long-term responders to CCBs was investigated in patients with idiopathic pulmonary arterial hypertension (IPAH). All acute responders were subsequently treated with high-dose CCB monotherapy, and 6-minute walk distances, hemodynamic data, and World Health Organization functional classifications were followed. Nine of 104 patients exhibited an acute response with intravenous adenosine (8.7%, 95% confidence interval 3.2 to 14.2). After 12 months of follow-up, all acute responders were still alive; however, only 6 patients showed sustained hemodynamic improvement (5.8%, 95% confidence interval 2 to 13). Three patients had failed CCB monotherapy and bosentan was added to their treatment. Mean tolerated dose of intravenous adenosine was 142 ± 49 μg/kg/min. No life-threatening adverse events were observed and only 2 patients of the nonresponders exhibited a 20% decrease in mean systemic arterial pressure. In nonresponders, 1- and 3-year survival rates were 89% and 75%, respectively. In conclusion, acute vasodilator testing with intravenous adenosine was safe and able to screen responders to CCB therapy in patients with IPAH. Long-term CCB responders accounted for about 5.8% of patients with IPAH. 相似文献
106.
Huan-Dong Liu Wei Li Zhen-Rui Chen Meng-Liang Zhou Zong Zhuang Ding-Ding Zhang Lin Zhu Chun-Hua Hang 《Neurological sciences》2013,34(7):1173-1180
Despite numerous researches and improvements in the past few years, the precise mechanisms underlying secondary brain injury after trauma remain obscure. Iron is essential for almost all types of cells, including nerve cells. However, excess of iron has been proved to contribute to the brain injury following trauma in animal models. As a key iron-handling protein in the brain, ferritin might be involved in iron-induced pathophysiological process of various brain disorders. Therefore, the current study was aimed to investigate the expression of ferritin in the human contused brain. Nineteen contused brain samples were obtained from 19 patients undergoing surgery for brain contusions 3 h–17 d after trauma, and three normal temporal pole samples from 3 patients with petroclival meningioma were collected as controls. Expression of ferritin-H-chain was measured by quantitative real-time polymerase chain reaction (PCR), western blot and immunohistochemistry, respectively. Perl’s reaction was taken for iron staining. The results showed that human traumatic brain injury (TBI) could up-regulate ferritin-H-chain in pericontusional cortex. A marked increase of ferritin was detected in the early group (≤12 h), and remained elevated for a long time till after 48 h post-injury. The location of ferritin-H-chain was found mainly at the neuron-like cells and seldom at glia-like cells. Perl’s reaction showed that most of the iron-positive cells were glia-like cells. These findings suggested that iron and ferritin might be involved in the secondary brain injury and could be therapeutic targets for patients with TBI. 相似文献
107.
Yijie Xu Afriyanti Sumboja Alexandra Groves Thomas Ashton Yun Zong Jawwad A. Darr 《RSC advances》2020,10(68):41871
Developing large-scale and high-performance OER (oxygen evolution reaction) and ORR (oxygen reduction reaction) catalysts have been a challenge for commercializing secondary zinc–air batteries. In this work, transition metal-doped cobalt–nickel sulfide spinels are directly produced via a continuous hydrothermal flow synthesis (CHFS) approach. The nanosized cobalt–nickel sulfides are doped with Ag, Fe, Mn, Cr, V, and Ti and evaluated as bifunctional OER and ORR catalyst for Zn–air battery application. Among the doped spinel catalysts, Mn-doped cobalt–nickel sulfides (Ni1.29Co1.49Mn0.22S4) exhibit the most promising OER and ORR performance, showing an ORR onset potential of 0.9 V vs. RHE and an OER overpotential of 348 mV measured at 10 mA cm−2, which is attributed to their high surface area, electronic structure of the dopant species, and the synergistic coupling of the dopant species with the active host cations. The dopant ions primarily alter the host cation composition, with the Mn(iii) cation linked to the introduction of active sites by its favourable electronic structure. A power density of 75 mW cm−2 is achieved at a current density of 140 mA cm−2 for the zinc–air battery using the manganese-doped catalyst, a 12% improvement over the undoped cobalt–nickel sulfide and superior to that of the battery with a commercial RuO2 catalyst.Transition metal-doped cobalt–nickel sulfide spinel (Ni1.29Co1.49Mn0.22S4) nanocatalysts for secondary Zn–air batteries with an efficient and stable electrochemical performance. 相似文献
108.
Y. Zhao R. Xue N. Shi Y. Xue Y. Zong W. Lin B. Pei C. Sun R. Fan Y. Jiang 《Osteoporosis international》2016,27(11):3309-3317
Summary
Patients with spinal cord deficits following new unstable osteoporotic compression fracture and surgical contraindications were considered to receive conservative treatment. Teriparatide was better than alendronate at improving bone mineral density and bone turnover parameters, as well as preventing aggravation of spinal cord compromise.Introduction
This study compared the preventive effects of teriparatide and alendronate on aggravation of spinal cord compromise following new unstable osteoporotic vertebral compression fracture (OVCF) in patients with surgical contraindications.Methods
This was a 12-month, randomized, open-label study of teriparatide versus alendronate in 49 patients with new unstable OVCF and surgical contraindications. Neurological function was evaluated using modified Japanese Orthopedic Association (mJOA) score (11-point scale, the maximum score of 11 implies normalcy). Visual analog scale (VAS) scores, kyphotic angles, anterior-border heights and diameters of the spinal canal of the fractured vertebrae, any incident of new OVCFs (onset of OVCF during follow-up), spine bone mineral density (BMD), and serum markers of bone resorption and bone formation were also examined at baseline and 1, 3, 6, and 12 months after initiation of the medication regimen.Results
At 12 months, mean mJOA score had improved in the teriparatide group and decreased in the alendronate group. Mean concentrations of bone formation and bone resorption biomarkers, mean spine BMD, and mean anterior-border height and spinal canal diameter of the fractured vertebrae were significantly greater in the teriparatide group than in the alendronate group. Mean VAS score, mean kyphotic angle of the fractured vertebrae, and incidence of new OVCFs were significantly smaller in the teriparatide group than in the alendronate group.Conclusions
In patients with neurological deficits following new unstable OVCF and with surgical contraindications, teriparatide was better than alendronate at improving the BMD and the bone turnover parameters, as well as preventing aggravation of spinal cord compromise.109.
Computer prediction of allergen proteins from sequence-derived protein structural and physicochemical properties 总被引:1,自引:0,他引:1
BACKGROUND: Computational methods have been developed for predicting allergen proteins from sequence segments that show identity, homology, or motif match to a known allergen. These methods achieve good prediction accuracies, but are less effective for novel proteins with no similarity to any known allergen. METHODS: This work tests the feasibility of using a statistical learning method, support vector machines, as such a method. The prediction system is trained and tested by using 1005 allergen proteins from the Allergome database and 22,469 non-allergen proteins from 7871 Pfam families. RESULTS: Testing results by an independent set of 229 allergen and 6717 non-allergen proteins from 7871 Pfam families show that 93.0% and 99.9% of these are correctly predicted, which are comparable to the best results of other methods. Of the 18 novel allergen proteins non-homologous to any other proteins in the Swissprot database, 88.9% is correctly predicted. A further screening of 168,128 proteins in the Swissprot database finds that 2.9% of the proteins are predicted as allergen proteins, which is consistent with the estimated numbers from motif-based methods. CONCLUSIONS: Our study suggests that SVM is a potentially useful method for predicting allergen proteins and it has certain capability for predicting novel allergen proteins. Our software can be accessed at . 相似文献
110.
目的 探讨双切口3至4块钢板固定治疗累及后内侧柱的Schatzker Ⅴ、Ⅵ型复杂胫骨平台骨折的临床疗效.方法 2013年1月至2015年12月采用前外侧联合后内侧倒L形双切口,外侧1块3.5 mm锁定钢板,内侧及后内侧2至3块3.5mm小钢板固定治疗累及后内侧柱的Schatzker Ⅴ、Ⅵ型复杂胫骨平台骨折患者15例,分析术后复位效果及随访时膝关节功能情况,评估手术临床疗效.结果 15例均获随访,随访时间18 ~30个月,平均24个月.术后骨折复位效果满意,末次随访时复位无丢失,骨折均愈合,膝关节活动度0 ~135°,平均115..膝关节功能采用HSS评分标准评定:优10例,良2例,可3例,差0例,优良率80%.结论 对于累及后内侧柱的SchatzkerⅤ、Ⅵ型复杂胫骨平台骨折,采用双切口,3至4块3.5 mm钢板固定,可以获得有效固定,膝关节功能恢复良好,并发症少,疗效满意. 相似文献